White Lauren 4
4 · C4 Therapeutics, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
White Lauren
Chief Financial Officer
Transactions
- Exercise/Conversion
Performance Restricted Stock Units
2022-05-25−3,750→ 22,500 totalExp: 2025-02-28→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock
2022-05-25+3,750→ 3,750 total
Footnotes (1)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.